PTC Therapeutics, Inc. Common Stock Offering
Davis Polk advised the lead book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 4,000,000 shares of common stock of PTC…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Chegg, Inc. $345 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Chegg, Inc. of $345 million aggregate principal amount of its 0.25% convertible…
Davis Polk Advises Charles River Laboratories International, Inc. on Its $500 Million Notes Offering
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.500% senior notes…
iQIYI, Inc. Initial Public Offering and NASDAQ Listing
Davis Polk advised the representatives of the underwriters on the SEC-registered initial public offering by iQIYI, Inc. of 125,000,000 American Depositary Shares, each representing seven…
Spotify Technology direct listing
Davis Polk advised the financial advisers to Spotify Technology S.A. in connection with Spotify’s direct listing of its ordinary shares on the New York Stock Exchange. The ordinary shares…
Rio Tinto Cash Tender Offer
Davis Polk advised the dealer managers in connection with a cash tender offer by Rio Tinto Finance plc to purchase certain of its euro-denominated debt securities.
Rio Tinto is a global…
Accelerate Diagnostics, Inc. $150 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Accelerate Diagnostics, Inc. of $150 million aggregate principal amount of its 2…
Davis Polk Advises Sunlands Online Education Group on Its Initial Public Offering and NYSE Listing
Davis Polk advised Sunlands Online Education Group on its SEC-registered initial public offering of 13,000,000 American depositary shares, each 25 ADSs representing one Class A ordinary…
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $1.5 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…
Bombardier Inc. C$638.4 Million Class B Shares
Davis Polk advised the underwriters in connection with a C$638.4 million offering of 168,000,000 Class B shares (subordinate voting) by Bombardier Inc. The offering included a public…